Precision medicines for intractable targets
A transformational small-molecule platform for rapid hit discovery and optimization against difficult-to-drug targets, taking fragments rapidly to development candidates.
Rapid hit to development candidate
We aim to transform the speed, cost and success rate of delivering small molecules against challenging targets.
No biophysical screening bottleneck
Breakthrough technology for functional screening of fragments combined with an AI-assisted SMART fragment library.
A faster path from hit to candidate
An automated, integrated chem-bio platform rapidly generates large, high-quality SAR data sets, with AI-enabled iterative analysis and optimization.
Orthosteric and allosteric
Highly effective for both orthosteric and allosteric modulators of difficult-to-drug targets.
Skipping the slow road
Conventional fragment-based drug discovery relies on biophysical screening, followed by a long, costly elaboration step to turn weak binders into potent leads.
Our platform starts from functionally active fragments and takes them directly toward development candidates, removing both bottlenecks.
Partner with Implexsys
We welcome conversations with collaborators, investors and future team members.